ReviewMikrochimica acta2025
Reproducibility roadblocks and standardization in carbon dot synthesis: a critical review of current practices, challenges, and future directions.
Review in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Surface engineered nitrogen doped carbon quantum dots for mechanistic understanding and advanced biosensing of antibiotic contaminants: a review.RSC advances · 2026Review
- Graphene Quantum Dots in Neurodegeneration: Protein Aggregation and the Microglial State as Therapeutic Targets.Nanomaterials (Basel, Switzerland) · 2026Review
- Green production of multi-functional carbon dots from agricultural corn silk waste: application in heavy metal (FeScientific reports · 2026Article
- Advances in green-synthesized quantum dot-based nanoplatforms for cancer treatment, photodynamic therapy, photothermal therapy and cancer theranostics.RSC advances · 2026Review
- Biomass based carbon quantum dots in sensor applications: a review (2021-2025).Bioresources and bioprocessing · 2026Review
- Carbon Nanodot-enabled Fluorescent Nerve Conduits for Peripheral Nerve Repair: A Systematic Review of Translational Readiness.Plastic and reconstructive surgery. Global open · 2026Article
- Carbon Dots in Nanomedicine: Advanced Fabrication, Biomedical Applications, and Future Clinical Perspectives.Pharmaceutics · 2026Review
- Carbon Dot-Based Electrochemical and Optical Sensors for Pharmaceutical Analysis and Point-of-Care Diagnostics.Biosensors · 2026Review
- Carbon dot-integrated edible films: emerging synergies for advanced food packaging applications.RSC advances · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbon dots (CDs) have emerged as promising nanomaterials due to their unique photoluminescent properties, biocompatibility, and wide-ranging applications in biomedicine, sensing, energy, and environmental monitoring. However, despite extensive research on their synthesis and applications, the field faces persistent challenges in reproducibility and standardization. Variability in synthetic approaches, such as differences in precursors, reaction conditions, and post-synthesis treatments, leads to inconsistent physicochemical and optical properties, which hinders both scientific progress and commercial translation. This review critically examines the current landscape of CDs synthesis methods and the influence of key variables on material quality. It also provides a comprehensive evaluation of characterization techniques for determining essential properties such as particle size, surface charge, quantum yield, and emission stability. Special emphasis is placed on the major barriers to reproducibility, including batch-to-batch inconsistency, ambiguous classification schemes, and non-uniform reporting practices. Unlike prior reviews that primarily focus on synthetic routes or end-use applications, this work uniquely addresses the systemic lack of standardization across laboratories, which is a key bottleneck to scaling and regulatory approval. By analyzing emerging efforts toward harmonized protocols and exploring the potential of machine learning for synthesis optimization, this review offers actionable recommendations such as the adoption of reference materials and universal reporting standards. These insights aim to guide the development of robust, reproducible, and application-ready CDs technologies.
Indexed as
Identifiers
41269331What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.